Long-Term Safety and Tolerability of Zavegepant 10 mg Nasal Spray During Concomitant Use of CGRP Monoclonal Antibodies: Results From a 1-Year Open-label Safety Trial

被引：2

作者：

Berman, Gary ^{[1
]}

Mullin, Kathleen ^{[2
]}

Pavlovic, Jelena ^{[3
]}

Smith, Timothy ^{[4
]}

Croop, Robert ^{[5
]}

Madonia, Jennifer ^{[5
]}

Mosher, Linda ^{[5
]}

Hould, Jennifer ^{[5
]}

Lipton, Richard ^{[3
]}

机构：

[1] Clin Res Inst, Minneapolis, MN USA

[2] New England Inst Neurol & Headache, Stamford, CT USA

[3] Albert Einstein Coll Med, New York, NY USA

[4] StudyMetrix Res, St Petersburg, FL USA

[5] Biohaven Pharmaceut, New Haven, CT USA

来源：

关键词：

D O I：

10.1212/WNL.0000000000203893

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P10-12.009

引用

页数：5